FDA Inspection 1140066 — Royal Canin U.S.A., Inc.

Royal Canin U.S.A., Inc. — FEI 3004256151

The FDA completed an inspection of Royal Canin U.S.A., Inc. on March 16, 2021 in Fremont, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 16, 2021
Fiscal Year
2021
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Fremont, NE (United States)